United States v. Rottschaefer

178 F. App'x 145
CourtCourt of Appeals for the Third Circuit
DecidedApril 27, 2006
Docket04-4015, 05-1229
StatusUnpublished
Cited by2 cases

This text of 178 F. App'x 145 (United States v. Rottschaefer) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Rottschaefer, 178 F. App'x 145 (3d Cir. 2006).

Opinion

OPINION OF THE COURT

RENDELL, Circuit Judge.

Bernard Rottschaefer, M.D. challenges his convictions and sentence on 153 counts of a 208-count indictment charging unlawful distribution of controlled substances, in violation of 21 U.S.C. § 841(a)(1). At trial, five of Rottschaefer’s patients testified that he fed their drug addictions by prescribing them Xanax, Oxycontin, and other addictive painkillers; four of them testified that they performed sexual favors in exchange for the prescriptions. Rottschaefer seeks a new trial based on alleged prosecutorial misconduct, ineffective assistance of counsel and evidence that a government witness perjured herself at trial. We conclude that these claims lack merit and will affirm Rottschaefer’s convictions. We will vacate his sentence and remand for resentencing in accordance with United States v. Booker, 543 U.S. 220, 125 S.Ct. 738, 160 L.Ed.2d 621 (2005).

I.

Rottschaefer’s prosecutorial misconduct and ineffective assistance claims are based on his theory that he was improperly tried and convicted under a medical malpractice or negligence standard, rather than the higher standard of proof *147 required for criminal convictions. 1 He argues that the “no legitimate medical reason” standard used by the prosecution throughout the trial, without defense objection, equates to a civil, rather than a criminal, standard of liability.

This argument finds no support in the law. The Controlled Substances Act (“CSA”), under which Rottschaefer was convicted, provides: “Except as authorized by this subchapter, it shall be unlawful for any person knowingly or intentionally — (1) to manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance.” 21 U.S.C. § 841(a)(1). Physicians are exempt from this provision to the extent that they act lawfully, see United, States v. Moore, 423 U.S. 122, 131, 96 S.Ct. 335, 46 L.Ed.2d 333 (1975), but they are subject to criminal liability when their drug prescribing and dispensing activities fall “outside the usual course of professional practice,” id. at 124, 96 S.Ct. 335. The CSA’s implementing regulations provide that, to be effective, a prescription “must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice,” and that a person who knowingly issues an ineffective prescription “shall be subject to the penalties provided for violations of the provisions of law relating to controlled substances.” 21 C.F.R. § 1306.04(a). Thus, the regulations clearly state that prescribing drugs for other than a “legitimate medical purpose” is a basis for criminal liability under the CSA.

Moreover, courts of appeals frequently use the “no legitimate medical purpose” standard to define physician liability under § 841(a)(1). For example, the Fifth Circuit Court of Appeals stated the elements of the offense as follows:

To convict Dr. Norris of violating 21 U.S.C. § 841(a)(1), the government was required to prove “(1) that he distributed or dispensed a controlled substance, (2) that he acted knowingly and intentionally, and (3) that he did so other than for a legitimate medical purpose and in the usual course of his professional practice.”

United States v. Norris, 780 F.2d 1207, 1209 (5th Cir.1986) (quoting United States v. Rosen, 582 F.2d 1032, 1033 (5th Cir. 1978)). The Court explained that, “[although the third element is not expressly required by § 841,” it derives from the language in the “pertinent regulations” quoted above. Id. (quoting 21 C.F.R. § 1306.04(a)). Other courts adopt the same approach. See, e.g., United States v. Nelson, 383 F.3d 1227, 1231-32 (10th Cir. 2004) (“A practitioner has unlawfully distributed a controlled substance if she prescribes the substance either outside the usual course of medical practice or without a legitimate medical purpose.”); United States v. Voorhies, 663 F.2d 30, 33 (6th Cir.1981) (rejecting defendant’s challenge to jury instruction based on 21 C.F.R. § 1306.04 and incorporating “other than a legitimate medical purpose” standard).

Finally, “there is considerable room to doubt whether” the distinction between the “no legitimate medical reason” and the “outside the usual course of professional practice” standards “is of any importance.” Nelson, 383 F.3d at 1231. Several courts have held that “there is no difference in *148 the meanings of the statutory phrase, ‘[i]n the course of professional practice’ and the regulations’ phrase, ‘legitimate medical purpose,’ ” United States v. Kirk, 584 F.2d-773, 784 (6th Cir.1978) (citing cases); the Fourth Circuit Court of Appeals goes even farther, holding that the “without a medical purpose” standard that Rottschaefer challenges is “more strict than [the “outside the usual course of professional practice” standard] required by Moore.” United States v. Cuong, 18 F.3d 1132, 1138 (4th Cir.1994) (emphasis added). As the Nelson court observed:

It is difficult to imagine circumstances in which a practitioner could have prescribed controlled substances within the usual course of medical practice but without a legitimate medical purpose. Similarly, it is difficult to imagine circumstances in which a practitioner could have prescribed controlled substances with a legitimate medical purpose and yet be outside the usual course of medical practice.

383 F.3d at 1231.

Thus, the prosecution acted well within the law when it defined Rottschaefer’s crimes in terms of prescribing narcotics for “no legitimate medical reason.” Rott-schaefer has not explained to our satisfaction how an improper standard was applied in his trial at all, much less how the application of that standard amounted to prosecutorial misconduct or ineffective assistance of counsel. We will not reverse his convictions on these grounds.

II.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Little
314 F. Supp. 3d 647 (E.D. Pennsylvania, 2018)
Motta v. Government of the Virgin Islands
49 V.I. 1025 (Virgin Islands, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
178 F. App'x 145, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-rottschaefer-ca3-2006.